University Hospital of Modena

Modena 71-41124

1 studies enrolling now · 4 studies all time

What they study most

Candidemia, Fungal Infection, HER2-Positive Primary Breast Cancer, Homeostatic Iron Regulator Gene-related Hereditary Hemochromatosis, Invasive Candidiases, Metastatic Breast Cancer, Mycoses, Residual Invasive Breast Cancer

Studies at this site

• Efficacy and Safety of Vamifeport in Adult Participants With Homeostatic Iron Regulator Gene (HFE)-Related Hereditary Hemochromatosis — Recruiting now
• A Study of Trastuzumab Deruxtecan (T-DXd) Versus Trastuzumab Emtansine (T-DM1) in High-risk HER2-positive Participants With Residual Invasive Breast Cancer Following Neoadjuvant Therapy (DESTINY-Breast05) — Running, not enrolling
• SYD985 vs. Physician's Choice in Participants With HER2-positive Locally Advanced or Metastatic Breast Cancer — Completed
• Study of Rezafungin Compared to Caspofungin in Subjects With Candidemia and/or Invasive Candidiasis — Completed